![]() |
Name |
Diaporthichalasin F
|
Molecular Formula | C28H37NO4 | |
IUPAC Name* |
(1R,2R,3E,5S,7R,9E,11R,12S,14S,15R,16S)-16-benzyl-2,7,12-trihydroxy-5,7,14-trimethyl-13-methylidene-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-18-one
|
|
SMILES |
C[C@H]\1C[C@](C/C=C/[C@H]2[C@@H](C(=C)[C@H]([C@@H]3[C@@]2([C@@H](/C=C1)O)C(=O)N[C@H]3CC4=CC=CC=C4)C)O)(C)O
|
|
InChI |
InChI=1S/C28H37NO4/c1-17-12-13-23(30)28-21(11-8-14-27(4,33)16-17)25(31)19(3)18(2)24(28)22(29-26(28)32)15-20-9-6-5-7-10-20/h5-13,17-18,21-25,30-31,33H,3,14-16H2,1-2,4H3,(H,29,32)/b11-8+,13-12+/t17-,18-,21+,22+,23-,24+,25-,27-,28-/m1/s1
|
|
InChIKey |
CPBCRDXOMYWIMA-OQRQTMPTSA-N
|
|
Synonyms |
Diaporthichalasin F
|
|
CAS | NA | |
PubChem CID | 156582433 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 451.6 | ALogp: | 2.8 |
HBD: | 4 | HBA: | 4 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 89.8 | Aromatic Rings: | 4 |
Heavy Atoms: | 33 | QED Weighted: | 0.513 |
Caco-2 Permeability: | -5.493 | MDCK Permeability: | 0.00001190 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.989 |
Human Intestinal Absorption (HIA): | 0.185 | 20% Bioavailability (F20%): | 0.742 |
30% Bioavailability (F30%): | 0.704 |
Blood-Brain-Barrier Penetration (BBB): | 0.225 | Plasma Protein Binding (PPB): | 75.64% |
Volume Distribution (VD): | 0.761 | Fu: | 8.89% |
CYP1A2-inhibitor: | 0.027 | CYP1A2-substrate: | 0.179 |
CYP2C19-inhibitor: | 0.109 | CYP2C19-substrate: | 0.765 |
CYP2C9-inhibitor: | 0.117 | CYP2C9-substrate: | 0.097 |
CYP2D6-inhibitor: | 0.011 | CYP2D6-substrate: | 0.124 |
CYP3A4-inhibitor: | 0.893 | CYP3A4-substrate: | 0.246 |
Clearance (CL): | 4.57 | Half-life (T1/2): | 0.17 |
hERG Blockers: | 0.235 | Human Hepatotoxicity (H-HT): | 0.531 |
Drug-inuced Liver Injury (DILI): | 0.155 | AMES Toxicity: | 0.014 |
Rat Oral Acute Toxicity: | 0.957 | Maximum Recommended Daily Dose: | 0.996 |
Skin Sensitization: | 0.149 | Carcinogencity: | 0.038 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.983 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004243 | ![]() |
0.784 | D06CWH | ![]() |
0.258 | ||
ENC006133 | ![]() |
0.782 | D0V3ZA | ![]() |
0.251 | ||
ENC004120 | ![]() |
0.760 | D0SP3D | ![]() |
0.251 | ||
ENC004369 | ![]() |
0.733 | D0I0DL | ![]() |
0.250 | ||
ENC004544 | ![]() |
0.729 | D0D7KC | ![]() |
0.245 | ||
ENC004918 | ![]() |
0.729 | D09NNH | ![]() |
0.244 | ||
ENC003955 | ![]() |
0.714 | D01TSI | ![]() |
0.244 | ||
ENC004118 | ![]() |
0.655 | D0R1BD | ![]() |
0.232 | ||
ENC003718 | ![]() |
0.655 | D0IN7I | ![]() |
0.228 | ||
ENC004468 | ![]() |
0.652 | D0TB8C | ![]() |
0.228 |